Sanjivani paranteral Limited has filed its mandatory annual disclosure with BSE Limited under SEBI's takeover regulations for the financial year ended 31st March, 2026. The pharmaceutical company submitted the required documentation on 2nd April, 2026, ensuring compliance with regulatory obligations.

Regulatory Compliance Details

The disclosure was made pursuant to Regulation 31(4) of the Securities Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Company Secretary Cum Compliance Officer Ravikumar Bogham submitted the filing to BSE Limited, which trades the company's shares under scrip code 531569.

Promoter Group Declaration

Promoter and Chairman Cum Managing Director Ashwani Khemka provided a comprehensive declaration on behalf of the promoter and promoter group. The declaration specifically confirmed that no encumbrance was made, directly or indirectly, over the company's shares during the financial year ended 31st March, 2026.

The promoter group declaration covered all members of the promoter and promoter group, including persons acting in concert with Sanjivani Paranteral Limited. This comprehensive coverage ensures full transparency regarding share ownership and potential encumbrances.

Corporate Governance Framework

The filing demonstrates the company's commitment to maintaining robust corporate governance standards and regulatory compliance. The disclosure was addressed to both BSE Limited's Corporate Relationship Department and the company's Audit Committee, ensuring proper oversight and documentation.

Sanjivani Paranteral Limited operates from its registered office at 205 P-N Kothari Industrial Estate, B S Marg Bhandup (W), Mumbai-400078, Maharashtra. The timely submission of this annual disclosure reflects the company's adherence to SEBI's substantial acquisition and takeover regulations.

Ashwani Khemka, Managing Director of Sanjivani Paranteral Limited, has disclosed another acquisition of additional equity shares in the company, further increasing his shareholding percentage as a promoter. The latest disclosure was made pursuant to Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Recent Share Acquisition Details

The latest acquisition involved 3,640 equity shares purchased through open market transactions on March 30, 2026. This represents 0.03% of the company's total share capital.

Updated Shareholding Position

Following this latest acquisition, Khemka's total shareholding in Sanjivani Paranteral Limited has increased to 29.60%. This follows his previous acquisition of 6,451 shares on March 27, 2026, which had increased his holding from 29.51% to 29.57%.

Company Capital Structure

Sanjivani Paranteral Limited's equity share capital structure remained unchanged following this transaction. The company maintains its existing capital base with no dilution or expansion.

Regulatory Compliance

The disclosure was filed with BSE Limited on March 31, 2026, where Sanjivani Paranteral Limited is listed under scrip code 531569. Khemka, holding DIN 00337118, submitted the required documentation as per SEBI regulations for substantial acquisition disclosures. The filing confirms his continued status as a promoter of the company and ensures transparency in shareholding changes above the prescribed thresholds.